Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3729733019 | Bevacizumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3729734013 | Product containing only bevacizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
2871821000001115 | Bevacizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
2871841000001113 | Bevacizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bevacizumab | Has active ingredient | Bevacizumab | true | Inferred relationship | Existential restriction modifier | 1 | |
Bevacizumab | Is a | Product containing bevacizumab | true | Inferred relationship | Existential restriction modifier | ||
Bevacizumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Bevacizumab | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Bevacizumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets